Hematology Second Opinion from US Blood Specialists
Independent review of your blood disorder or hematologic cancer diagnosis by U.S. board-certified hematologists. Delivered remotely, in 14 days.
What do you need reviewed?
Select the specialty that fits your case.
What Our Hematologists Review
Blood cancers and bone marrow disorders are molecularly complex, and treatment decisions depend on cytogenetics, molecular markers, and rapidly evolving guidelines. Our review confirms the classification and whether the proposed treatment reflects current NCCN recommendations.
Pathology & Bone Marrow Review
Re-evaluation of bone marrow biopsy, peripheral blood smear, and lymph node pathology, confirming diagnosis, classification, and risk stratification.
Molecular & Cytogenetic Analysis
Review of chromosomal studies, FISH results, flow cytometry, and molecular markers (JAK2, BCR-ABL, FLT3, NPM1) to confirm disease classification and guide treatment.
Treatment Protocol
Assessment of your proposed chemotherapy, targeted therapy, or immunotherapy regimen against NCCN hematology guidelines.
Transplant Eligibility Review
Independent assessment of stem cell transplant candidacy, timing, donor selection, and whether transplant is indicated in your specific case.
Clotting & Bleeding Disorders
Expert review of thrombophilia workup, anticoagulation management, and treatment plans for conditions including DVT, PE, hemophilia, and thrombocytopenia.
Multidisciplinary Input
For hematologic malignancies, your case draws on input from bone marrow transplant specialists, hematopathology, and hematologic oncology.
When to Seek a Hematology Second Opinion
- check_circleYou have been diagnosed with a blood cancer (leukemia, lymphoma, myeloma, or MDS) and want an independent review before starting treatment
- check_circleA bone marrow biopsy has been done and you want confirmation of the diagnosis and risk classification
- check_circleA stem cell transplant has been recommended and you want a second view on timing and indication
- check_circleYour blood counts are abnormal and no clear diagnosis has been established
- check_circleYou have a clotting or bleeding disorder and want to review your management plan
- check_circleYour hematologic cancer has relapsed and you want an independent view on the treatment options being proposed
Frequently Asked Questions
How does a hematology second opinion from the U.S. work?
expand_more
Upload your bone marrow biopsy report, peripheral blood smear results, flow cytometry, cytogenetics, molecular studies, and proposed treatment plan. A U.S. board-certified hematologist reviews all materials and delivers a written second opinion within 14 days. For complex cases, a live video consultation is also available.
Can a U.S. hematologist review my bone marrow biopsy remotely?
expand_more
Yes. Bone marrow biopsy pathology reports (including morphology, immunohistochemistry, flow cytometry, and cytogenetic findings) can be reviewed from digitized results. Expert remote review of hematopathology is standard practice in hematology consultation.
What if the U.S. specialist reads the case differently?
expand_more
Hematologic malignancy treatment (particularly for AML, MDS, CLL, and myeloma) has evolved significantly with newer targeted therapies. A different recommendation gives you documented, guideline-based reasoning for discussing with your hematologist in India, and may point to treatment approaches that have not yet been considered.
Which blood conditions do you cover?
expand_more
We cover the full range of hematology including acute and chronic leukemia (AML, ALL, CML, CLL), lymphoma (Hodgkin's and non-Hodgkin's), multiple myeloma, myelodysplastic syndrome, myeloproliferative neoplasms (ET, PV, MF), aplastic anemia, hemolytic anemia, ITP, hemophilia, thrombophilia, DVT and PE management, and stem cell transplant evaluation.
How long does the review take?
expand_more
Most hematology second opinions are delivered within 14 days of receiving complete records. Urgent cases can be prioritized. You will be notified if additional laboratory or pathology results are needed before review begins.
Get Your Hematology Second Opinion
U.S. board-certified hematologists. Independent review. Delivered in 14 days.